Results
|
|
4941.
|
|
|
|
4942.
|
|
|
|
4943.
|
|
|
|
4944.
|
|
|
|
4945.
|
Enhanced incorporation of 1-beta-D-arabinofuranosylcytosine by pretreatment with etoposide. [electronic resource] by
- Ooi, K
- Ohkubo, T
- Kuwabara, H
- Higashigawa, M
- Kawasaki, H
- Kakitoh, H
- Kagawa, Y
- Inagaki, S
- Sumida, K
- Sakurai, M
Producer: 19930811
In:
Cancer investigation vol. 11
Availability: No items available.
|
|
|
4946.
|
|
|
|
4947.
|
|
|
|
4948.
|
|
|
|
4949.
|
|
|
|
4950.
|
[Continuous infusion therapy with low dose cytosine arabinoside and etoposide in acute myelogenous leukemia patients hardly tolerable for intensive combination chemotherapy]. [electronic resource] by
- Tsurumi, H
- Miura, T
- Yamada, T
- Sawada, M
- Nakamura, N
- Tomoda, T
- Takahashi, T
- Oyama, M
- Moriwaki, H
- Muto, Y
Producer: 19951027
In:
[Rinsho ketsueki] The Japanese journal of clinical hematology vol. 36
Availability: No items available.
|
|
|
4951.
|
|
|
|
4952.
|
|
|
|
4953.
|
|
|
|
4954.
|
|
|
|
4955.
|
|
|
|
4956.
|
|
|
|
4957.
|
|
|
|
4958.
|
|
|
|
4959.
|
A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. Turkish Oncology Group. [electronic resource] by
- Içli, F
- Celik, I
- Aykan, F
- Uner, A
- Demirkazik, A
- Ozet, A
- Ozgüroğlu, M
- Taş, F
- Akbulut, H
- Firat, D
Producer: 19990112
In:
Cancer vol. 83
Availability: No items available.
|
|
|
4960.
|
|